Over the past two years (early 2023 to early 2025), MRNA stock has shown significant volatility, culminating in a sharp decline. It peaked at $197.02 in early 2023, then trended downwards before a recovery period in late 2023 and early 2024, reaching a secondary high near $170 by mid-2024.

Subsequently, the stock experienced a dramatic and sustained plunge throughout the latter half of 2024. It hit its lowest point of $36.85 by late 2024 and currently trades around the $40-$45 mark as of early 2025. This represents a substantial net depreciation from its starting point and its average price of $107.33 over the period.